Yen‐Yang Chen

1.1k total citations
70 papers, 785 citations indexed

About

Yen‐Yang Chen is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yen‐Yang Chen has authored 70 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 31 papers in Surgery and 24 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yen‐Yang Chen's work include Pancreatic and Hepatic Oncology Research (21 papers), Neuroendocrine Tumor Research Advances (14 papers) and Hepatocellular Carcinoma Treatment and Prognosis (14 papers). Yen‐Yang Chen is often cited by papers focused on Pancreatic and Hepatic Oncology Research (21 papers), Neuroendocrine Tumor Research Advances (14 papers) and Hepatocellular Carcinoma Treatment and Prognosis (14 papers). Yen‐Yang Chen collaborates with scholars based in Taiwan, South Korea and United States. Yen‐Yang Chen's co-authors include Jen‐Shi Chen, Li‐Tzong Chen, Kun‐Ming Rau, Wen‐Chi Chou, Yuan‐Hung Kuo, Tai‐Jan Chiu, Chien‐Feng Li, Chang‐Hsien Lu, Hsuan‐Ying Huang and Yu‐Li Su and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yen‐Yang Chen

66 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yen‐Yang Chen Taiwan 17 342 300 241 169 138 70 785
Ömer Yerci Türkiye 16 281 0.8× 256 0.9× 168 0.7× 208 1.2× 125 0.9× 76 891
Yanzhi Hsu United States 16 340 1.0× 192 0.6× 429 1.8× 108 0.6× 91 0.7× 42 891
Annette Jappe Switzerland 11 227 0.7× 280 0.9× 242 1.0× 241 1.4× 117 0.8× 14 1.1k
Stefano Tamberi Italy 20 555 1.6× 276 0.9× 303 1.3× 176 1.0× 221 1.6× 59 1.0k
Natsuko Okita Japan 20 855 2.5× 271 0.9× 518 2.1× 278 1.6× 135 1.0× 110 1.3k
Marta Martín-Richard Spain 17 483 1.4× 190 0.6× 238 1.0× 150 0.9× 148 1.1× 42 708
Yu-Hong Li China 15 606 1.8× 285 0.9× 392 1.6× 110 0.7× 205 1.5× 19 922
Kojiro Eto Japan 17 396 1.2× 437 1.5× 444 1.8× 229 1.4× 174 1.3× 92 1.0k
Yoshinori Hirashima Japan 13 335 1.0× 93 0.3× 238 1.0× 155 0.9× 65 0.5× 29 572
Katrina S. Pedersen United States 15 661 1.9× 293 1.0× 220 0.9× 202 1.2× 170 1.2× 73 970

Countries citing papers authored by Yen‐Yang Chen

Since Specialization
Citations

This map shows the geographic impact of Yen‐Yang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yen‐Yang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yen‐Yang Chen more than expected).

Fields of papers citing papers by Yen‐Yang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yen‐Yang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yen‐Yang Chen. The network helps show where Yen‐Yang Chen may publish in the future.

Co-authorship network of co-authors of Yen‐Yang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yen‐Yang Chen. A scholar is included among the top collaborators of Yen‐Yang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yen‐Yang Chen. Yen‐Yang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yen‐Yang, et al.. (2026). Mediterranean Diet Adherence Is Associated With Reduced Liver Fibrosis Risk in Metabolic Dysfunction–Associated Steatotic Liver Disease. Journal of Gastroenterology and Hepatology. 41(3). 1041–1051.
2.
Su, Yung‐Yeh, Nai‐Jung Chiang, Yi‐Hsin Yang, et al.. (2023). Real-World Data Validation of NAPOLI-1 Nomogram for the Prediction of Overall Survival in Metastatic Pancreatic Cancer. Cancers. 15(4). 1008–1008. 5 indexed citations
3.
Fu, Jachih, Chen‐Chi Wang, Chun‐Yi Chuang, et al.. (2023). A cascade deep learning model for diagnosing pharyngeal acid reflux episodes using hypopharyngeal multichannel intraluminal Impedance-pH signals. Intelligence-Based Medicine. 8. 100131–100131. 2 indexed citations
4.
Su, Yung‐Yeh, Nai‐Jung Chiang, Tai‐Jan Chiu, et al.. (2023). Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation. Biomedical Journal. 47(3). 100696–100696. 1 indexed citations
5.
6.
Chen, Yen‐Yang, Chen‐Chi Wang, John Y. Kao, et al.. (2023). Validation of Pharyngeal Acid Reflux Episodes Using Hypopharyngeal Multichannel Intraluminal Impedance-pH. Journal of Neurogastroenterology and Motility. 29(1). 49–57. 7 indexed citations
7.
Chen, Yen‐Hao, Yen‐Yang Chen, Chih‐Chi Wang, et al.. (2023). Real-world comparison of pembrolizumab and nivolumab in advanced hepatocellular carcinoma. BMC Cancer. 23(1). 810–810. 11 indexed citations
8.
9.
Su, Yung‐Yeh, Nai‐Jung Chiang, Chung‐Pin Li, et al.. (2022). Dosing Pattern and Early Cumulative Dose of Liposomal Irinotecan in Metastatic Pancreatic Cancer: A Real-World Multicenter Study. Frontiers in Oncology. 12. 800842–800842. 6 indexed citations
11.
Chen, Yen‐Yang, et al.. (2020). Efficacy and safety of uracil-tegafur in patients with recurrent or metastatic thymic carcinoma. Journal of Cancer Research and Practice. 7(3). 111–111. 1 indexed citations
12.
Yen, Yi‐Hao, Yu‐Fan Cheng, Jing‐Houng Wang, et al.. (2020). Real world clinical practice in treating advanced hepatocellular carcinoma: When East meets West. PLoS ONE. 15(3). e0230005–e0230005. 7 indexed citations
14.
Li, Chien‐Feng, Fu‐Min Fang, Yen‐Yang Chen, et al.. (2017). Overexpressed Fatty Acid Synthase in Gastrointestinal Stromal Tumors: Targeting a Progression-Associated Metabolic Driver Enhances the Antitumor Effect of Imatinib. Clinical Cancer Research. 23(16). 4908–4918. 33 indexed citations
15.
Huang, Cheng-Hua, et al.. (2016). Tailored Selection of First-Line Cisplatin-Based Chemotherapy in Patients with Metastatic Urothelial Carcinoma of Bladder. Journal of Cancer. 7(10). 1347–1352. 8 indexed citations
17.
Ma, Ming‐Chun, Yen‐Yang Chen, Shau-Hsuan Li, et al.. (2014). Intra-Arterial Chemotherapy with Doxorubicin and Cisplatin Is Effective for Advanced Hepatocellular Cell Carcinoma. The Scientific World JOURNAL. 2014. 1–8. 14 indexed citations
18.
Liu, Chien-Ting, Yi‐Chun Chiu, & Yen‐Yang Chen. (2014). Multiple Endocrine Neoplasia Type 1 With Gastric Neuroendocrine Tumor Presented With Gastric Polyposis. Clinical Gastroenterology and Hepatology. 13(5). e45–e45. 1 indexed citations
19.
Su, Yu‐Li, Yen‐Yang Chen, Hui‐Chun Chen, et al.. (2013). Post-mastectomy radiotherapy benefits subgroups of breast cancer patients with T1-2 tumor and 1–3 axillary lymph node(s) metastasis. Radiology and Oncology. 48(3). 314–322. 30 indexed citations
20.
Rau, Kun‐Ming, Chao‐Cheng Huang, Tai‐Jan Chiu, et al.. (2012). Neovascularization evaluated by CD105 correlates well with prognostic factors in breast cancers. Experimental and Therapeutic Medicine. 4(2). 231–236. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026